Crossmark

Disruptions in Tiopronin therapy: impacts on clinical outcomes of pediatric cystinuria patients during the COVID-19 pandemic

Crossref DOI link: https://doi.org/10.1007/s00240-025-01767-4

Published Online: 2025-05-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Önal, Hülya Gözde https://orcid.org/0000-0002-3691-0933
Nalçacioğlu, Hülya https://orcid.org/0000-0002-0686-9714
Karali, Demet Tekcan https://orcid.org/0000-0001-7013-1354
Ceyhan Bilgici, Meltem Necibe https://orcid.org/0000-0002-0133-0234
Aydog, Ozlem https://orcid.org/0000-0002-2157-7226
Özkaya, Ozan https://orcid.org/0000-0002-0198-1221
Özdem, Ender https://orcid.org/0000-0003-3196-4024
Sarikaya, Saban https://orcid.org/0000-0003-3479-2002
Funding

Funding for this research was provided by:

Ondokuz Mayıs University
License Information

Text and Data Mining valid from 2025-05-30

Version of Record valid from 2025-05-30
More Information

Article History

Received: 18 May 2024

Accepted: 13 May 2025

First Online: 30 May 2025

Declarations

:

: The authors declare no competing interests.